Fethi Yönet
Research Subjects
Fethi Yönet has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Yasin Öztürk
Department of Nephrology, Bülent Ecevit University, 67100 Zonguldak, Türkiye
12 shared publications - Hakan Ozer
Department of Nephrology Izmir Bakircay University İzmir Turkey
11 shared publications - Ismail Baloglu
Department of Nephrology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey
11 shared publications - Kultigin Turkmen
Department of Nephrology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey
9 shared publications - Halil Zeki Tonbul
Division of Nephrology, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye
6 shared publications - Nedim Yılmaz Selcuk
Department of Nephrology, Department of Internal Medicine, Meram Faculty of Medicine, Necmettin Erbakan University, 42080 Konya, Turkey
5 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 8, 164-173
Silent Brain Lesions in Chronic Kidney Disease: A Hidden Burden
Objective: Silent brain lesions (SBL), including silent brain infarction (SBI) and subcortical white matter lesions (SWML), are increasingly recognized as important radiological markers of cerebral small vessel disease. Patients with chronic kidney disease (CKD) may be at increased risk due to shared vascular and metabolic abnormalities. This study aimed to investigate the prevalence, radiological characteristics, and predictors of SBL in patients with CKD.Methods: This retrospective study included 276 patients with CKD who underwent brain magnetic resonance imaging (MRI) between March 2020 and March 2021. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m², and patients undergoing hemodialysis were included. MRI findings were classified as SBI, SWML, overt stroke, or no lesion. Silent brain lesions were defined as the presence of SBI and/or SWML in patients without a clinical history of stroke or focal neurological deficits. Clinical and laboratory data were analyzed, and independent predictors were determined using binary logistic regression.Results: Pathological MRI findings were detected in 177 patients (64.1%). Among them, 131 patients (74.0%) had SBL (73 SWML and 58 SBI), while 46 (26.0%) had overt stroke. Patients with SBL were older and had a higher prevalence of diabetes mellitus and hypertension compared with those with overt stroke. In multivariate logistic regression analysis, older age (OR: 1.073, 95% CI: 1.051–1.096; p < 0.001) and higher serum creatinine levels (OR: 1.306, 95% CI: 1.096–1.557; p = 0.003) were identified as independent predictors of SBL. Among patients with SBL, those with SWML had a longer duration of hemodialysis compared to those with SBI.Conclusion: Silent brain lesions are highly prevalent in patients with CKD. Older age and impaired renal function are independent predictors of SBL. These findings highlight the importance of cerebrovascular risk assessment in CKD patients, particularly in older individuals and those with advanced renal dysfunction.
- 8 September 2026
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 8, 164-173
Open AccessSilent Brain Lesions in Chronic Kidney Disease: A Hidden Burden
Objective: Silent brain lesions (SBL), including silent brain infarction (SBI) and subcortical white matter lesions (SWML), are increasingly recognized as important radiological markers of cerebral small vessel disease. Patients with chronic kidney disease (CKD) may be at increased risk due to shared vascular and metabolic abnormalities. This study aimed to investigate the prevalence, radiological characteristics, and predictors of SBL in patients with CKD.Methods: This retrospective study included 276 patients with CKD who underwent brain magnetic resonance imaging (MRI) between March 2020 and March 2021. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m², and patients undergoing hemodialysis were included. MRI findings were classified as SBI, SWML, overt stroke, or no lesion. Silent brain lesions were defined as the presence of SBI and/or SWML in patients without a clinical history of stroke or focal neurological deficits. Clinical and laboratory data were analyzed, and independent predictors were determined using binary logistic regression.Results: Pathological MRI findings were detected in 177 patients (64.1%). Among them, 131 patients (74.0%) had SBL (73 SWML and 58 SBI), while 46 (26.0%) had overt stroke. Patients with SBL were older and had a higher prevalence of diabetes mellitus and hypertension compared with those with overt stroke. In multivariate logistic regression analysis, older age (OR: 1.073, 95% CI: 1.051–1.096; p < 0.001) and higher serum creatinine levels (OR: 1.306, 95% CI: 1.096–1.557; p = 0.003) were identified as independent predictors of SBL. Among patients with SBL, those with SWML had a longer duration of hemodialysis compared to those with SBI.Conclusion: Silent brain lesions are highly prevalent in patients with CKD. Older age and impaired renal function are independent predictors of SBL. These findings highlight the importance of cerebrovascular risk assessment in CKD patients, particularly in older individuals and those with advanced renal dysfunction.
- Open Access
- 28 August 2026
- Published by Springer Nature in BMC Nephrology
The relationship between urinary MMP-9, proteinuria, and pulse wave velocity in patients with diabetic kidney disease: a cross-sectional study
- 28 August 2026
- Published by Springer Nature in BMC Nephrology
Open AccessThe relationship between urinary MMP-9, proteinuria, and pulse wave velocity in patients with diabetic kidney disease: a cross-sectional study
- Open Access
- 29 July 2025
- Published by Dahiliye uzmanlari dernegi (DAHUDER) in DAHUDER Medical Journal
- Vol. 5 (3) , 89-95
In Which Hemodialysis Patients Have Covid-19 Cause Death More Often?
Background: We aimed to reveal the frequency, prognosis and factors affecting the prognosis of coronavirus disease 2019 (COVID-19) in hemodialysis patients. Methods: The frequency, symptoms (fever, throat ache, cough, weakness and diarrhea), laboratory findings (lymphocyte count and ratio, ferritin, c-reactive protein, d-dimer and fibrinogen), duration of hemodialysis, hemodialysis adequacy (determined by KtV Ure) and factors affecting patients who recovered or died of COVID-19 infection in chronic hemodialysis patients (n=730) in 5 different centers were investigated. Results: COVID-19 infection occurred in 141 of 730 patients in the 13-month period (19.3%), and twenty-nine died (20.5%). While the mean age of those who died was higher than those who recovered, the duration of hemodialysis treatment, gender distribution, and mean Kt/V were not different. The number of comorbidities was higher in patients who died than in those who recovered. Additional diseases such as type 2 diabetes mellitus, coronary artery disease, and heart failure were found at a higher rate in patients who died. Conclusion: Mortality rates in hemodialysis patients were found to be higher than in the general population, and similar to the general population, death was more common in patients with higher comorbidity and cardiovascular disease compared to patients who recovered. Since cardiovascular diseases are common in chronic hemodialysis patients, death from COVID-19 may be higher.
- 29 July 2025
- Published by Dahiliye uzmanlari dernegi (DAHUDER) in DAHUDER Medical Journal
- Vol. 5 (3) , 89-95
Open AccessIn Which Hemodialysis Patients Have Covid-19 Cause Death More Often?
Background: We aimed to reveal the frequency, prognosis and factors affecting the prognosis of coronavirus disease 2019 (COVID-19) in hemodialysis patients. Methods: The frequency, symptoms (fever, throat ache, cough, weakness and diarrhea), laboratory findings (lymphocyte count and ratio, ferritin, c-reactive protein, d-dimer and fibrinogen), duration of hemodialysis, hemodialysis adequacy (determined by KtV Ure) and factors affecting patients who recovered or died of COVID-19 infection in chronic hemodialysis patients (n=730) in 5 different centers were investigated. Results: COVID-19 infection occurred in 141 of 730 patients in the 13-month period (19.3%), and twenty-nine died (20.5%). While the mean age of those who died was higher than those who recovered, the duration of hemodialysis treatment, gender distribution, and mean Kt/V were not different. The number of comorbidities was higher in patients who died than in those who recovered. Additional diseases such as type 2 diabetes mellitus, coronary artery disease, and heart failure were found at a higher rate in patients who died. Conclusion: Mortality rates in hemodialysis patients were found to be higher than in the general population, and similar to the general population, death was more common in patients with higher comorbidity and cardiovascular disease compared to patients who recovered. Since cardiovascular diseases are common in chronic hemodialysis patients, death from COVID-19 may be higher.
- Open Access
- 20 June 2025
- Published by MediHealth Academy in Kastamonu Medical Journal
- Vol. 5 (2) , 99-102
How did the COVID-19 pandemic period affect the patients on the cadaver waiting list? A single-center experience
Aims: During the COVID-19 pandemic, kidney transplantations have decreased worldwide and in Turkiye. This study aimed to explore the expected increase in the number of patients on the cadaver waiting list and the factors influencing this outcome. Methods: We analyzed data from kidney transplant candidates during the pandemic period, focusing on mortality rates, causes of death, and patient behavior, such as attendance to routine transplant polyclinic visits. Results: Although an increase in the number of patients on the cadaver waiting list was expected, a decrease was reported in some centers. Mortality rates were higher in kidney transplant candidates due to COVID-19, but the highest death rate was still attributed to cardiovascular diseases. Additionally, the number of patients attending routine transplant polyclinic visits decreased due to fear of infection. Conclusion: The expected increase in patients on the cadaver waiting list was not observed, likely due to higher mortality rates and decreased clinic visits during the pandemic. The dilemma of transplantation and infection during the pandemic is a challenging issue, requiring careful follow-up in experienced centers.
- 20 June 2025
- Published by MediHealth Academy in Kastamonu Medical Journal
- Vol. 5 (2) , 99-102
Open AccessHow did the COVID-19 pandemic period affect the patients on the cadaver waiting list? A single-center experience
Aims: During the COVID-19 pandemic, kidney transplantations have decreased worldwide and in Turkiye. This study aimed to explore the expected increase in the number of patients on the cadaver waiting list and the factors influencing this outcome. Methods: We analyzed data from kidney transplant candidates during the pandemic period, focusing on mortality rates, causes of death, and patient behavior, such as attendance to routine transplant polyclinic visits. Results: Although an increase in the number of patients on the cadaver waiting list was expected, a decrease was reported in some centers. Mortality rates were higher in kidney transplant candidates due to COVID-19, but the highest death rate was still attributed to cardiovascular diseases. Additionally, the number of patients attending routine transplant polyclinic visits decreased due to fear of infection. Conclusion: The expected increase in patients on the cadaver waiting list was not observed, likely due to higher mortality rates and decreased clinic visits during the pandemic. The dilemma of transplantation and infection during the pandemic is a challenging issue, requiring careful follow-up in experienced centers.
- Open Access
- 30 April 2024
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 6 (2) , 97-101
Acute cholestatic hepatitis due to infectious mononucleosis: A case report
Cholestatic hepatitis is a rare complication of acute Epstein-Barr virus (EBV) infection. Here, we presented a case of acute cholestatic hepatitis secondary to acute infectious mononucleosis, who presented with complaints of abdominal pain, yellowing of the eyes and body, itching, widespread body pain, fever, nausea and vomiting. It was emphasized that EBV infection should also be considered in the differential diagnosis of cholestatic hepatitis etiology.
- 30 April 2024
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 6 (2) , 97-101
Open AccessAcute cholestatic hepatitis due to infectious mononucleosis: A case report
Cholestatic hepatitis is a rare complication of acute Epstein-Barr virus (EBV) infection. Here, we presented a case of acute cholestatic hepatitis secondary to acute infectious mononucleosis, who presented with complaints of abdominal pain, yellowing of the eyes and body, itching, widespread body pain, fever, nausea and vomiting. It was emphasized that EBV infection should also be considered in the differential diagnosis of cholestatic hepatitis etiology.
- 22 November 2023
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 28 (2) , 234-239
Overlooked factor in the etiology of pruritus in hemodialysis patients: Ultrafiltration volume
Introduction: This study investigated the relationship between ultrafiltration (UF) volume and pruritus severity based on the idea that skin perfusion and inflammatory changes occur in dialysis patients with high UF volume.Materials and Methods: This observational study included 392 patients. Patients filled out the Numerical Rating Scale, Verbal Rating Scale, and Visual Analogue Scale, showing the severity of pruritis. UF volumes in the last 12 sessions were recorded and averaged.Results: The rate of patients with pruritis was between 59.4% and 67.5% in the three scales. In three pruritis scales, the severity of pruritis, age, body mass index (BMI), UF volume, and UF volume/body weight ratio were positively correlated. UF volume/body weight ratio, age, and BMI were independent predictors of pruritis severity.Conclusion: Limiting interdialytic weight gain may be an important treatment approach in pruritus control.
- 22 November 2023
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 28 (2) , 234-239
Overlooked factor in the etiology of pruritus in hemodialysis patients: Ultrafiltration volume
Introduction: This study investigated the relationship between ultrafiltration (UF) volume and pruritus severity based on the idea that skin perfusion and inflammatory changes occur in dialysis patients with high UF volume.Materials and Methods: This observational study included 392 patients. Patients filled out the Numerical Rating Scale, Verbal Rating Scale, and Visual Analogue Scale, showing the severity of pruritis. UF volumes in the last 12 sessions were recorded and averaged.Results: The rate of patients with pruritis was between 59.4% and 67.5% in the three scales. In three pruritis scales, the severity of pruritis, age, body mass index (BMI), UF volume, and UF volume/body weight ratio were positively correlated. UF volume/body weight ratio, age, and BMI were independent predictors of pruritis severity.Conclusion: Limiting interdialytic weight gain may be an important treatment approach in pruritus control.
- Open Access
- 31 August 2023
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 33 (4) , 384-389
Monocyte-HDL Ratio: Can It Be Included in the Follow-Up of Diabetes Mellitus and Diagnosis of Diabetic Nephropathy?
Background and Aim: Diabetic nephropathy is the most common cause of end-stage renal disease and albuminuria is the earliest manifestation of diabetic nephropathy.Oxidative stress and inflammation caused by advanced glyco-oxidation end products contribute to micro and macrovascular complications of diabetes. Monocyte to high-density lipoprotein (HDL) cholesterol ratio (MHR) is an essential indicator of inflammation and oxidative stress. In this study, we aimed to reveal the relationship between diabetes regulation and complications and MHR. Material and Method: A total of 182 subjects, including 152 patients with diabetes mellitus (DM) and 30 healthy controls, were included in this study. All data of the subjects were scanned retrospectively. The DM group was divided into two groups nephropathy (n=68) and non-nephropathy (n=84), with a limit of 30 mg/day for albuminuria. MHR was calculated by dividing the monocyte count by the HDL cholesterol count. Results: When patients with DM were divided into nephropathy and non-nephropathy, patients with nephropathy had higher MHR levels than the other group. We showed that MHR correlated with albuminuria, creatinine, and HbA1c in patients with diabetic nephropathy. In addition, in the regression analysis, albuminuria and MHR were predictors of DN, while MHR, age, and creatinine were found to be independent predictors of albuminuria. Conclusion: MHR, which is an easily calculated marker with simple laboratory tests, which is frequently requested in routine practice in the follow-up of diabetes patients, can help predict the regulation of diabetes and its kidney complications.
- 31 August 2023
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 33 (4) , 384-389
Open AccessMonocyte-HDL Ratio: Can It Be Included in the Follow-Up of Diabetes Mellitus and Diagnosis of Diabetic Nephropathy?
Background and Aim: Diabetic nephropathy is the most common cause of end-stage renal disease and albuminuria is the earliest manifestation of diabetic nephropathy.Oxidative stress and inflammation caused by advanced glyco-oxidation end products contribute to micro and macrovascular complications of diabetes. Monocyte to high-density lipoprotein (HDL) cholesterol ratio (MHR) is an essential indicator of inflammation and oxidative stress. In this study, we aimed to reveal the relationship between diabetes regulation and complications and MHR. Material and Method: A total of 182 subjects, including 152 patients with diabetes mellitus (DM) and 30 healthy controls, were included in this study. All data of the subjects were scanned retrospectively. The DM group was divided into two groups nephropathy (n=68) and non-nephropathy (n=84), with a limit of 30 mg/day for albuminuria. MHR was calculated by dividing the monocyte count by the HDL cholesterol count. Results: When patients with DM were divided into nephropathy and non-nephropathy, patients with nephropathy had higher MHR levels than the other group. We showed that MHR correlated with albuminuria, creatinine, and HbA1c in patients with diabetic nephropathy. In addition, in the regression analysis, albuminuria and MHR were predictors of DN, while MHR, age, and creatinine were found to be independent predictors of albuminuria. Conclusion: MHR, which is an easily calculated marker with simple laboratory tests, which is frequently requested in routine practice in the follow-up of diabetes patients, can help predict the regulation of diabetes and its kidney complications.
- Open Access
- 11 May 2023
- Published by Elsevier in Nefrología (English Edition)
- Vol. 44 (2) , 217-223
Is just enzyme replacement therapy enough for Fabry disease treatment? Have we missed a trick?
- 11 May 2023
- Published by Elsevier in Nefrología (English Edition)
- Vol. 44 (2) , 217-223
Open AccessIs just enzyme replacement therapy enough for Fabry disease treatment? Have we missed a trick?
- Open Access
- 29 April 2023
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 5 (2) , 84-91
Evaluation of Hearing and Auditory Pathways in Fabry Disease Patients
Background Hearing and the auditory pathway are affected in Fabry diseases (FD). There is limited data on hearing and auditory pathways in this population. Therefore, we aimed to investigate auditory functions and auditory pathways using auditory brainstem responses (ABR), otoacoustic distortion emission (DPOAE), pure tone audiometry (PTA), and tympanometry in patients with FD and to compare these results with those of healthy individuals. Material and Methods This study included 16 patients with FD (F/M: 8/8, age: 33.5±15.4 years) and 16 healthy controls (F/M: 5/11, age: 33.6±6.3 years). Hearing functions and auditory pathways were assessed with ABR, DPOAE, PTA, and tympanometry. Results According to the results of PTA, conductive hearing loss was detected in 4 (25%) of the patients with FD. When the 500-4,000 Hz frequencies were assessed, the bone pathway hearing threshold in both ears was significantly higher in the patients with FD than in the control group (p=0.014 and p=0.014, respectively). When we compared the DPOAE measurements of the patients with FD and the control groups, the dB value measured at 2.8 kHz was significantly lower in the patient group than in the control group (p=0.018). When we compared the ABR measurements, the right ear's 3-5 interpeak latency at 60 dB was significantly lower in the patient with FD than in the control group (1.8±0.3 ms vs 2±0.2 ms, p=0.033). Conclusions We found that the hearing loss rate and hearing threshold were statistically significantly higher in FD patients than in the control group. Hearing screening should be systematically performed in these patients.
- 29 April 2023
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 5 (2) , 84-91
Open AccessEvaluation of Hearing and Auditory Pathways in Fabry Disease Patients
Background Hearing and the auditory pathway are affected in Fabry diseases (FD). There is limited data on hearing and auditory pathways in this population. Therefore, we aimed to investigate auditory functions and auditory pathways using auditory brainstem responses (ABR), otoacoustic distortion emission (DPOAE), pure tone audiometry (PTA), and tympanometry in patients with FD and to compare these results with those of healthy individuals. Material and Methods This study included 16 patients with FD (F/M: 8/8, age: 33.5±15.4 years) and 16 healthy controls (F/M: 5/11, age: 33.6±6.3 years). Hearing functions and auditory pathways were assessed with ABR, DPOAE, PTA, and tympanometry. Results According to the results of PTA, conductive hearing loss was detected in 4 (25%) of the patients with FD. When the 500-4,000 Hz frequencies were assessed, the bone pathway hearing threshold in both ears was significantly higher in the patients with FD than in the control group (p=0.014 and p=0.014, respectively). When we compared the DPOAE measurements of the patients with FD and the control groups, the dB value measured at 2.8 kHz was significantly lower in the patient group than in the control group (p=0.018). When we compared the ABR measurements, the right ear's 3-5 interpeak latency at 60 dB was significantly lower in the patient with FD than in the control group (1.8±0.3 ms vs 2±0.2 ms, p=0.033). Conclusions We found that the hearing loss rate and hearing threshold were statistically significantly higher in FD patients than in the control group. Hearing screening should be systematically performed in these patients.
- Open Access
- 29 April 2023
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 5 (2) , 124-134
Factors Affecting Kidney Functions in One-Year Follow-up After COVID-19 in Kidney Transplant Patients
Background Coronavirus disease (COVID-19) is more severe, and mortality is higher in kidney transplantation (KTx) patients; it is still unclear how renal functions progress and the conditions affecting renal functions in the post-COVID-19 period. We aimed to investigate the changes in kidney functions and the factors affecting this change after COVID-19. Material and Methods Forty-one kidney transplantation patients who were hospitalised for COVID-19 were included in this retrospective study. The patient's personal information, examination, and treatment information regarding their hospitalisation and follow-ups were obtained from the hospital system. Results Patients with elevated serum creatinine in the first year post-COVID had higher baseline proteinuria and systemic immune inflammation index (SII). Proteinuria increased more in patients with a long transplantation period, hypertension, high basal creatinine, and SII. Also, proteinuria was higher in patients who developed AKI during the COVID period. In addition, baseline SII was an independent predictor of the change in serum creatinine and proteinuria. Conclusions We found that patients with signs of increased inflammation, such as high SII were more fragile regarding renal functions. Therefore, the post-COVID-19 follow-up process of KTx patients with COVID-19 should be individualised.
- 29 April 2023
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 5 (2) , 124-134
Open AccessFactors Affecting Kidney Functions in One-Year Follow-up After COVID-19 in Kidney Transplant Patients
Background Coronavirus disease (COVID-19) is more severe, and mortality is higher in kidney transplantation (KTx) patients; it is still unclear how renal functions progress and the conditions affecting renal functions in the post-COVID-19 period. We aimed to investigate the changes in kidney functions and the factors affecting this change after COVID-19. Material and Methods Forty-one kidney transplantation patients who were hospitalised for COVID-19 were included in this retrospective study. The patient's personal information, examination, and treatment information regarding their hospitalisation and follow-ups were obtained from the hospital system. Results Patients with elevated serum creatinine in the first year post-COVID had higher baseline proteinuria and systemic immune inflammation index (SII). Proteinuria increased more in patients with a long transplantation period, hypertension, high basal creatinine, and SII. Also, proteinuria was higher in patients who developed AKI during the COVID period. In addition, baseline SII was an independent predictor of the change in serum creatinine and proteinuria. Conclusions We found that patients with signs of increased inflammation, such as high SII were more fragile regarding renal functions. Therefore, the post-COVID-19 follow-up process of KTx patients with COVID-19 should be individualised.